Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Oberoi HK"'
Publikováno v:
Austin Journal of Cancer and Clinical Research. 8
Regular Physical Activity (PA) improves the outcomes of patients with cancer mainly by enhancing the immune system. The relationship of PA and the derived Neutrophil-to-Lymphocyte Ratio (dNLR) with the evolution of 31 consecutive patients with Recurr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f7fb74550081bff8377d92b3af35377
https://doi.org/10.26420/austinjcancerclinres.2021.1086
https://doi.org/10.26420/austinjcancerclinres.2021.1086
Autor:
Vadithya AS; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, India., Singh I; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, India., Rani U; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, India., Venadan S; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, India., Jajoriya R; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, India., Singh M; ICAR-National Bureau of Plant Genetic Resources Regional Station, Shimla, India., Oberoi HK; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, India., Singh S; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, India., Bharadwaj C; Division of Genetics, ICAR- Indian Agricultural Research Institute, New Delhi, India., Bindra S; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, India.
Publikováno v:
Frontiers in plant science [Front Plant Sci] 2024 Sep 27; Vol. 15, pp. 1461280. Date of Electronic Publication: 2024 Sep 27 (Print Publication: 2024).
Autor:
Arora V; Department of Microbiology, Punjab Agricultural University, Ludhiana, 141004, India., Pandove G; School of Organic Farming, Punjab Agricultural University, Ludhiana, 141004, India. gpandove@pau.edu., Brar SK; Punjab Agricultural University, Regional Research Station, Bathinda, 151001, India., Oberoi HK; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, 141004, India., Kalia A; Electron Microscopy and Nanoscience Laboratory, Department of Soil Science, PAU, Ludhiana, 141004, India.
Publikováno v:
Current microbiology [Curr Microbiol] 2024 May 14; Vol. 81 (7), pp. 172. Date of Electronic Publication: 2024 May 14.
Autor:
Kaur H; Department of Biochemistry, Punjab Agricultural University, Ludhiana, 141004 India., Oberoi HK; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, 141004 India., Ganapathy KN; Plant Breeding Unit, ICAR-Indian Institute of Millets Research, Hyderabad, 500030 India., Bhardwaj R; Department of Plant Breeding and Genetics, Punjab Agricultural University, Ludhiana, 141004 India.
Publikováno v:
Journal of food science and technology [J Food Sci Technol] 2023 Sep; Vol. 60 (9), pp. 2370-2384. Date of Electronic Publication: 2023 Jun 18.
Autor:
Serra-Bellver P; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom. Electronic address: p.serra@nhs.net., Versluis JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Oberoi HK; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Zhou C; Cancer Research UK Manchester Institute Cancer Biomarker Centre, University of Manchester, United Kingdom., Slattery TD; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Khan Y; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Patrinely JR; Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Pires da Silva I; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Westmead and Blacktown Hospital, Sydney, Australia., Martínez-Vila C; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain., Cook N; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom., Graham DM; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom., Carlino MS; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Westmead and Blacktown Hospital, Sydney, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia., Arance AM; Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain., Johnson DB; Department of Medical Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Long GV; Melanoma Institute Australia, The University of Sydney and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia., Pickering L; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Larkin JMG; Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, United Kingdom., Blank CU; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lorigan P; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, United Kingdom.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 176, pp. 121-132. Date of Electronic Publication: 2022 Oct 07.
Autor:
Pires da Silva I; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia.; Westmead and Blacktown Hospitals, Sydney, Australia., Ahmed T; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., McQuade JL; The University of Texas MD Anderson Cancer Center, Houston, TX., Nebhan CA; Vanderbilt University Medical Center, Nashville, TN., Park JJ; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia., Versluis JM; Netherlands Cancer Institute, Amsterdam, the Netherlands., Serra-Bellver P; The Christie NHS Foundation Trust, Manchester, United Kingdom., Khan Y; The Christie NHS Foundation Trust, Manchester, United Kingdom., Slattery T; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Oberoi HK; Hospital Clinic, Barcelona & IDIBAPS, Barcelona, Spain., Ugurel S; University Hospital Essen, University of Duisburg-Essen, German Cancer Consortium, Partner Site Essen, Essen, Germany., Haydu LE; Westmead and Blacktown Hospitals, Sydney, Australia., Herbst R; Helios Klinikum Erfurt, Erfurt, Germany., Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany., Pföhler C; Saarland University Medical Center, Homburg/Saar, Germany., Terheyden P; Department of Dermatology, University of Lübeck, Lübeck, Germany., Weichenthal M; University Skin Cancer Center Kiel, University Hospital of Schleswig-Holstein, Kiel, Germany., Gutzmer R; Skin Cancer Center, Department of Dermatology, Mühlenkreiskliniken, Ruhr University Bochum Campus Minden, Minden, Germany., Mohr P; Elbe-Klinikum Buxtehude, Buxtehude, Germany., Rai R; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Smith JL; Westmead and Blacktown Hospitals, Sydney, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia., Arance AM; Hospital Clinic, Barcelona & IDIBAPS, Barcelona, Spain., Pickering L; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Larkin J; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Lorigan P; The Christie NHS Foundation Trust, Manchester, United Kingdom.; Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom., Blank CU; Netherlands Cancer Institute, Amsterdam, the Netherlands., Schadendorf D; University Hospital Essen, University of Duisburg-Essen, German Cancer Consortium, Partner Site Essen, Essen, Germany., Davies MA; The University of Texas MD Anderson Cancer Center, Houston, TX., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Westmead and Blacktown Hospitals, Sydney, Australia., Johnson DB; Vanderbilt University Medical Center, Nashville, TN., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, Australia.; Royal North Shore and Mater Hospitals, Sydney, Australia., Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia.; Royal North Shore and Mater Hospitals, Sydney, Australia.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Apr 01; Vol. 40 (10), pp. 1068-1080. Date of Electronic Publication: 2022 Feb 10.
Autor:
Oberoi HK; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Garralda E; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. egarralda@vhio.net.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Aug 15; Vol. 27 (16), pp. 4459-4461. Date of Electronic Publication: 2021 Jun 16.
Autor:
Mayà-Casalprim G; Servicio de Neurología, Hospital Clínic, Barcelona, España., Serrano E; Servicio de Radiodiagnóstico, Hospital Sagrat Cor, Barcelona, España., Oberoi HK; Servicio de Oncología, Hospital Clínic, Barcelona, España., Llull L; Servicio de Neurología, Hospital Clínic, Barcelona, España. Electronic address: BLLLULL@clinic.cat.
Publikováno v:
Neurologia (Barcelona, Spain) [Neurologia (Engl Ed)] 2020 Oct; Vol. 35 (8), pp. 599-601. Date of Electronic Publication: 2019 Jul 22.